Related Experiment Video
Updated: Jun 23, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
[Tigecycline: Its position between other antibiotics, features, clinical usage]
1Dept. Infect. Dis. 3rd Med. Faculty, Charles Univ., Prague. benes.infekce@seznam.cz
Klinicka Mikrobiologie a Infekcni Lekarstvi
|April 29, 2009
Summary
Tigecycline, a glycylcycline antibiotic, shows high effectiveness and low resistance affinity. While approved for skin and abdominal infections, its potential extends to other serious bacterial conditions, excluding sepsis.
Area of Science:
- Pharmacology
- Infectious Diseases
- Microbiology
Background:
- Tigecycline represents a novel class of antibiotics, the glycylcyclines.
- Derived from tetracyclines, it exhibits enhanced efficacy, reduced susceptibility to resistance mechanisms, and an extended half-life.
- Currently approved for specific infections, its broader therapeutic potential is under investigation.
Purpose of the Study:
- To evaluate the current registered uses of tigecycline.
- To explore potential expanded therapeutic applications for tigecycline.
- To identify infections where tigecycline may not be suitable.
Main Methods:
- Literature review of tigecycline's properties and clinical applications.
- Analysis of tigecycline's pharmacokinetic and pharmacodynamic profiles.
- Comparison of tigecycline's spectrum of activity against various pathogens.
Main Results:
- Tigecycline is registered for treating skin/soft tissue and complicated intra-abdominal infections.
- Potential expanded uses include pneumonia, STDs, multi-resistant H. pylori, biofilm-associated infections, and intracellular pathogens (brucellosis, Q-fever, rickettsial infections).
- Tigecycline is considered inappropriate for sepsis and acute life-threatening bacterial diseases.
Conclusions:
- Tigecycline is a valuable antibiotic with a defined role in treating specific complex infections.
- Its efficacy against resistant and intracellular pathogens suggests broader applications.
- Careful consideration of its limitations, particularly in acute, severe conditions like sepsis, is crucial for optimal patient outcomes.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
00:57Antibiotic Selection
Overview
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...